Biocrossroads lands $2.8 million Lilly Endowment grant
The advocate for the state’s life sciences industry has now pulled in more than $25 million from the endowment.
Lilly Endowment
Articles
Wabash lands $6.2M grant from Lilly Endowment
Wabash College is getting a $6.2 million grant to boost a center's efforts to support professors who teach religious studies or theology.
Lilly Endowment’s value holds steady at $5.3 billion
Eli Lilly and Co. stock, which accounts for 91 percent of the endowment’s assets, was worth nearly $4.8 billion at the end of 2010, a 2-percent drop over the previous year.
Housing group gets $6.3 million from Lilly Endowment
Lilly Endowment Inc. is continuing its decades-long support of the Indianapolis Neighborhood Housing Partnership, awarding the not-for-profit a $6.3 million grant to help low- and middle-income families become homeowners.
Lilly Endowment gives $35M to start pharmacy school
Manchester College will use money to launch the state’s third program offering doctorates in pharmacy.
Ivy Tech gets $23M to renovate old Stouffer’s Hotel building
Grant from Lilly Endowment will create a workforce training center, space for distance education and administrative offices at 45-year-old former hotel on North Meridian Street.
Christian Theological Seminary to search for new president
The current president will retire next June 30 but continue in an advisory role as the school begins to develop new educational approaches.
United Way steps in to help Morgan County’s flood repair
The grant came from a $45 million pool created by Lilly Endowment Inc. in 2008.
IU gets $4 million grant for new research center
IU will use its Lilly Endowment grant to open its news Center for Law, Ethics and Applied Research in Health Information.
Lilly Endowment’s value drops to $5.3 billion
Lilly Endowment announced Monday that its assets declined 7 percent, to $5.3 billion, in 2009, as the foundation continued
to lose money on Eli Lilly and Co. stock.
SKARBECK: Diversifying not sure fix for Lilly Endowment woes
Lilly Endowment has been a substantial Lilly stockholder for 73 years, so to focus on the past decade is a mistake.
Lilly Endowment’s assets drop more than foundation peers
Once the nation’s wealthiest foundation, Indianapolis-based Lilly Endowment now ranks ninth among its grant-making
peers. The endowment’s value fell 15 percent last year, to an estimated $4.8 billion.
Market surge doesn’t lift Lilly Endowment
Lilly Endowment’s resistance to diversify its holdings reached a new height last year, as it failed to sell a single share
of the underperforming Eli Lilly and Co. stock while the broader market surged.
Ballard solicits business help in aid of Indy Parks
Corporate contributions, volunteerism help shore up struggling city department after recession-driven cuts reduce budget by
nearly one-fifth.
Lilly Endowment gives another $6 million to ISU institute
Philanthropic giant has gifted $29 million since 2003 to fund research and education in financial services.
Conexus gets $3.45 million from Lilly Endowment
Lilly Endowment Inc. is continuing to support the state’s advanced-manufacturing initiative, giving Conexus Indiana a grant to help connect potential workers with the necessary training.
Death of heiress Ruth Lilly unleashes more philanthropy
Lilly’s death on Dec. 30 at age 94 will trigger the release of hundreds of millions of dollars from her
estate, with perhaps as much as $200 million flowing to the fledgling Ruth Lilly Charitable Foundation.
Nature Conservancy nets another $1M for building
Lilly Endowment will give The Nature Conservancy in Indiana $1 million for its headquarters building, possibly reducing
the need for extensive borrowing.
Lilly Endowment’s two-fer
Its education focus just might make the endowment more of a jobs engine than the Indiana Economic Development Corp.
$60M Lilly Endowment grant to fund IU physician research
Indiana University, which has received nearly $600 million from the endowment over the last three decades, will leverage the
new gift to increase its
scientific discoveries and commercialize life science innovations.